Well, in our law, to get a patent for a "new form of a known substance," you must show it works significantly better, not just change salt or crystal. The Glivec judgment was a strong dawai against evergreening—it said you cannot simply re-patent an old medicine with small changes to extend your monopoly and keep prices high.
From my window, I see the relief when a generic arrives and a patient's monthly bill drops from a lakh to a few thousand rupees. That is the real test, na? When my own wife needs her knee operation, I understand the cost of a monopoly—every month I save for my granddaughter, I think, what if her future medicine was kept artificially expensive?
#athletics#track-and-field
Jump in to reply — no account needed.